CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update
05 mai 2022 15h19 HE
|
atai Life Sciences
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued yesterday under the headline "atai Life Sciences to Announce First-Quarter 2022 Financial Results" by atai Life Sciences N.V. (Nasdaq:...
atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 vor
04 mai 2022 14h10 HE
|
atai Life Sciences
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen im klinischen Stadium, das anstrebt, die Behandlung von psychischen...
atai Life Sciences to Announce First-Quarter 2022 Financial Results
04 mai 2022 04h00 HE
|
atai Life Sciences
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
atai Life Sciences ist Teilnehmer der im April stattfindenden Investorenkonferenz
20 avr. 2022 12h04 HE
|
atai Life Sciences
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen für den klinischen Bereich, das sich der Aufgabe verschrieben hat,...
atai Life Sciences to Participate in Upcoming April Investor Conference
19 avr. 2022 12h26 HE
|
atai Life Sciences
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform
30 mars 2022 06h59 HE
|
atai Life Sciences
– Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in...
atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update
23 mars 2022 06h59 HE
|
atai Life Sciences
NEW YORK and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...
atai Life Sciences to Participate in Upcoming March Investor Conferences
21 mars 2022 13h08 HE
|
atai Life Sciences
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
atai Impact spendet an die Multidisciplinary Association for Psychedelic Studies (MAPS), um deren Pionierarbeit in der psychedelischen Medizin zu unterstützen
16 févr. 2022 17h47 HE
|
atai Life Sciences
- Führende gemeinnützige und kommerzielle Organisationen der psychedelischen Wissenschaft teilen die Vision von der Heilung psychischer Erkrankungen - Die Spende kommt von atai Impact, dem...
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine
16 févr. 2022 06h59 HE
|
atai Life Sciences
- Leading non-profit and commercial organizations in psychedelic science united in visions to heal mental health conditions - Donation is from atai Impact, the philanthropic arm of mental health...